Influence of pharmaceutical care on the delayed emesis associated with chemotherapy.

Abstract:

BACKGROUND:Complete control of emesis during chemotherapy remains to be achieved. This could be improved by increasing adherence to medicines and recommendations. OBJECTIVE:The aim of this study was to analyse the effects of pharmaceutical care on the incidence of delayed chemotherapy-induced nausea and vomiting (CINV) in adult cancer outpatients. METHOD:This is a longitudinal prospective intervention study. Patients included were those who received a new cancer intravenous treatment. We compared complete response (no vomiting and no rescue treatment) and the incidence of nausea in the control group (CG) and in the intervention group (IG), as well as patients' adherence. Pharmaceutical intervention consisted of: reviewing the antiemetic protocol and giving some recommendations to the patients. RESULTS:102 patients were studied. In the delayed phase complete response was achieved in 84.8 % of the patients in the IG, compared with 69.6 % in the control group [absolute risk reduction (ARR), 15.2 %; p = 0.144]. Regarding absence of vomiting, the difference was higher (71.0 CG vs 97.0 % IG, ARR, 26.0%; p = 0.002). Absence of delayed nausea were also better in the IG (61 vs. 52 %). Compliant patients increased from 59 to 76 %. CONCLUSION:The intervention of a pharmacist reduced the incidence of delayed CINV and improved medication adherence.

journal_name

Int J Clin Pharm

authors

Caracuel F,Baños Ú,Herrera MD,Ramírez G,Muñoz N

doi

10.1007/s11096-014-9915-z

subject

Has Abstract

pub_date

2014-04-01 00:00:00

pages

287-90

issue

2

eissn

2210-7703

issn

2210-7711

journal_volume

36

pub_type

杂志文章
  • Understanding management of poorly controlled pain in community-dwelling analgesic users: a qualitative study.

    abstract::Background Chronic pain is a prevalent and debilitating condition for many people. Globally it is the greatest contributor to years lived with disability. Management often includes pharmacotherapy and pharmacists are therefore well placed to contribute to chronic pain management. Objective To explore chronic pain mana...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-020-01198-8

    authors: Wilson AJ,Spark MJ

    更新日期:2020-11-27 00:00:00

  • The relationship between patients' knowledge of diabetes therapeutic goals and self-management behaviour, including adherence.

    abstract::Background The Middle East region has one the highest prevalence rates of diabetes in the world. Little is known about the determinants of adherence and the role of knowledge in diabetes self-management within these populations. Objective To investigate the relationship between patients knowledge of diabetes therapeut...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章,多中心研究

    doi:10.1007/s11096-016-0375-5

    authors: Waheedi M,Awad A,Hatoum HT,Enlund H

    更新日期:2017-02-01 00:00:00

  • INR optimization based on stroke risk factors in patients with non-valvular atrial fibrillation.

    abstract:BACKGROUND:Bleeding complications have been frequently reported in East Asian patients on warfarin with a target international normalized ratio (INR) of 2.0-3.0. OBJECTIVE:This study aimed to identify the optimal therapeutic range of the INR in Korean patients with non-valvular atrial fibrillation (NVAF). Setting Card...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-015-0149-5

    authors: Chung JE,Choi YR,Seong JM,La HO,Gwak HS

    更新日期:2015-12-01 00:00:00

  • Discontinuation of antipsychotics treatment for elderly patients within a specialized behavioural unit: a retrospective review.

    abstract::Background Best practice guidelines recommend regular evaluation of antipsychotics in managing behaviours for dementia patients with a view to de-prescribing, given its significant mortality and adverse outcomes (Reus et al. in Am J Psychiatry 173(5):543-546, 2016, Deprescribing Guidelines and Algorithms in https://de...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-020-01135-9

    authors: Gao RL,Lim KS,Luthra AS

    更新日期:2020-09-10 00:00:00

  • Efficiency of adalimumab, etanercept and infliximab in ankylosing spondylitis in clinical practice.

    abstract:BACKGROUND:Information on the use of ankylosing spondylitis (AS) therapies in clinical practice is a key factor in decision making, as more efficient treatments may involve substantial savings while maintaining the clinical benefits for the patient. OBJECTIVE:To assess the mean annual doses and associated costs of the...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-015-0124-1

    authors: Escudero-Vilaplana V,Ramírez-Herráiz E,Alañón-Plaza E,Trovato-López N,García-Vicuña R,Carreño-Pérez L,Morell-Baladrón A,Sanjurjo-Sáez M

    更新日期:2015-10-01 00:00:00

  • Prescribing pattern of antihypertensive drugs in a general hospital in central China.

    abstract:OBJECTIVES:To examine the prescribing pattern of antihypertensive drugs in outpatients with hypertension in a general hospital in central China and identify whether the pattern of prescribing is appropriate and in accordance with national and international guidelines for pharmacotherapy of hypertension. SETTING:The in...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-010-9476-8

    authors: Cheng H

    更新日期:2011-04-01 00:00:00

  • Communicating medication changes to community pharmacy post-discharge: the good, the bad, and the improvements.

    abstract:BACKGROUND:Communication between hospital and community pharmacists when a patient is discharged from hospital can improve the accuracy of medication reconciliation, thus preventing unintentional changes and ensuring continuity of supply. It allows problems to be resolved before a patient requires a further supply of m...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-013-9813-9

    authors: Urban R,Paloumpi E,Rana N,Morgan J

    更新日期:2013-10-01 00:00:00

  • Bridging the gap between hospital and primary care: the pharmacist home visit.

    abstract::Bridging the gap between hospital and primary care is important as transition from one healthcare setting to another increases the risk on drug-related problems and consequent readmissions. To reduce those risks, pharmacist interventions during and after hospitalization have been frequently studied, albeit with variab...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-015-0093-4

    authors: Ensing HT,Koster ES,Stuijt CC,van Dooren AA,Bouvy ML

    更新日期:2015-06-01 00:00:00

  • Development of a decision support system for the practice of responsible self-medication.

    abstract:BACKGROUND:Responsible self-medication is an integral part of the health system that consists of community pharmacists counseling patients on treating minor illness using non-prescription medications. Systems for properly managing information can assist disease identification and clinical decision-making. OBJECTIVE:To...

    journal_title:International journal of clinical pharmacy

    pub_type: 共识发展会议,杂志文章

    doi:10.1007/s11096-015-0223-z

    authors: da Rocha CE,Lessa FA,Venceslau DO,Sakuraba CS,Barros IM,de Lyra DP Jr

    更新日期:2016-02-01 00:00:00

  • Doctors' perceptions, expectations and experience regarding the role of pharmacist in hospital settings of Pakistan.

    abstract::Background The inclusion of pharmacist in health care system is essential to ensure optimal patient care. However, with the passage of time, pharmacist's role has transcended from dispensing, compounding and counting of pills, to more sophisticated clinical duties. Objective To evaluate doctors' experience, perception...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-020-00991-9

    authors: Khan N,McGarry K,Naqvi AA,Holden K

    更新日期:2020-04-01 00:00:00

  • Potentially inappropriate medications in Chinese community-dwelling older adults.

    abstract::Background There is a lack of data on the prevalence of potentially inappropriate medications (PIMs) in community-dwelling older adults in China. Objective To assess the prevalence of potentially inappropriate medication in community dwelling older adults in China and to investigate risk factors associated with the us...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-020-00980-y

    authors: Huang Y,Zhang L,Huang X,Liu K,Yu Y,Xiao J

    更新日期:2020-04-01 00:00:00

  • Effects of a pharmacotherapy follow-up in community pharmacies on type 2 diabetes patients in Brazil.

    abstract:OBJECTIVE:To evaluate the effects of pharmacotherapy follow-up (PF) on metabolic control and clinical outcomes in type 2 diabetic patients. SETTING:Six community pharmacies (4 intervention and 2 control) in the Curitiba metropolitan region (Brazil). MAIN OUTCOME MEASURE:Glycosylated Haemoglobin A1 (HbA1) and fasting ...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-011-9493-2

    authors: Correr CJ,Melchiors AC,Fernandez-Llimos F,Pontarolo R

    更新日期:2011-04-01 00:00:00

  • Off-label and unlicensed prescribing in Europe: implications for patients' informed consent and liability.

    abstract::This article reviews the implications of off-label (OL) and unlicensed (UL) medicine use with respect to the legal duty to inform patients and the liability for failure to provide the patient with adequate information on benefits and risks. Informed consent is a legal prerequisite to any medical treatment and requires...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-018-0646-4

    authors: Aagaard L,Kristensen K

    更新日期:2018-06-01 00:00:00

  • Drug allergy documentation--time for a change?

    abstract:OBJECTIVE OF THE STUDY:To audit patients' allergy documentation in a large rural hospital an to make recommendations about accurate drug allergies in hospital settings. SETTING:A 257 bed large hospital and fully integrated health service in Australia, providing a range of services including; medicine, surgery, aged ca...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章,随机对照试验

    doi:10.1007/s11096-011-9525-y

    authors: Khalil H,Leversha A,Khalil V

    更新日期:2011-08-01 00:00:00

  • South Asian and Middle Eastern patients' perspectives on medicine-related problems in the United Kingdom.

    abstract:BACKGROUND:There has been little research which specifically examines medicine use among South Asian (SA) and Middle Eastern (ME) groups, although evidence suggests that medicine-related needs may be poorly met for these groups. OBJECTIVE:To describe medicine-related problems (MRPs) experienced by SA and ME patients f...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-015-0103-6

    authors: Alhomoud F,Dhillon S,Aslanpour Z,Smith F

    更新日期:2015-08-01 00:00:00

  • Screening for impaired liver function as a risk factor for drug safety at hospital admission of surgical patients.

    abstract::Background Hepatic insufficiency can affect patient safety and should therefore be considered during drug therapy. Hospital admission offers an ideal point to screen for patients at risk and to adjust drug therapy accordingly. Objective To assess the number of patients admitted to hospital with clinically elevated liv...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-019-00948-7

    authors: Strobach D,Poppele A,Mannell H,Andraschko M,Schiek S,Bertsche T

    更新日期:2020-02-01 00:00:00

  • Recommendations to support deprescribing medications late in life.

    abstract::It is widely acknowledged that patients-particularly those late in life-are frequently exposed to the harms of medication. To minimize these harms, several frameworks have been developed by which prescribing can be optimized. In the context of diminishing life expectancy, these frameworks can be used to reduce medicat...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-015-0148-6

    authors: Todd A,Holmes HM

    更新日期:2015-10-01 00:00:00

  • Incidence of muscle relaxant use in relation to diagnosis of Parkinson's disease.

    abstract::Background Parkinson's disease is the second most common neurodegenerative disorder. Motor and non-motor symptoms seem to precede the diagnosis of Parkinson's disease. Objective To evaluate the incidence of muscle relaxant use in community-dwelling persons with and without Parkinson's disease from 4 years before to 4 ...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-020-01002-7

    authors: Paakinaho A,Karttunen N,Koponen M,Taipale H,Tolppanen AM,Hartikainen S,Tiihonen M

    更新日期:2020-04-01 00:00:00

  • The treatment-related experiences of parents, children and young people with regular prescribed medication.

    abstract::Background Taking regular medication has been shown to have an impact on the daily lives of patients and their families. Objective To explore the medication-related experiences of patients and their families when a child or young person is prescribed regular medication. Setting A specialist U.K. paediatric hospital. M...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-018-0756-z

    authors: Aston J,Wilson KA,Terry DRP

    更新日期:2019-02-01 00:00:00

  • The hidden magnitude of polypharmacy: using defined daily doses and maximum licensed daily doses to measure antipsychotic load.

    abstract::Background Antipsychotic polypharmacy ("polypharmacy") is the concurrent prescribing of more than one antipsychotic. It is widely practised, as reported in the literature, and is known to increase the risk of adverse outcomes for patients. Objective To quantify the prevalence and magnitude of polypharmacy in patients ...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-019-00930-3

    authors: Nguyen ML,Sunderland B,Lim S,Hattingh L,Chalmers L

    更新日期:2019-12-01 00:00:00

  • What do hospital staff in the UK think are the causes of penicillin medication errors?

    abstract:BACKGROUND:Medication errors are a potential major threat to patient's health, and allergic reactions occurring in patients with known allergies are an important preventable form of adverse drug event. The use of penicillin antibiotics in patients who are allergic to penicillin, in particular, is a major concern. AIM:...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-012-9708-1

    authors: Wilcock M,Harding G,Moore L,Nicholls I,Powell N,Stratton J

    更新日期:2013-02-01 00:00:00

  • Allergic rhinitis characterization in community pharmacy customers: a cross-sectional study.

    abstract::Background Allergic rhinitis represents a public health problem that is significantly prevalent in the global population and has been associated with asthma, a strong desire to sleep and a low quality of life. Objective This study aims to evaluate the prevalence, symptoms, control strategies and treatment, as well as ...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-020-01115-z

    authors: Guedes H,Morgado M,Rodrigues M,Cruz A,Fonseca C,Costa E,Araujo ARTS

    更新日期:2020-09-20 00:00:00

  • Knowledge of cardiovascular disease risk factors and practice of primary prevention of cardiovascular disease by Community Pharmacists in Nigeria: a cross-sectional study.

    abstract::Background Studies in international literature have shown that Community Pharmacists can make considerable impact in controlling cardiovascular disease risk factors, especially hypertension. In Nigeria, there are no studies on the knowledge of CVD risk factors by Community Pharmacists and their practice of primary pre...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-018-0744-3

    authors: Amadi CE,Lawal FO,Mbakwem AC,Ajuluchukwu JN,Oke DA

    更新日期:2018-12-01 00:00:00

  • 47th ESCP symposium on clinical pharmacy Personalised pharmacy care. 24-26 October 2018, Belfast, Northern Ireland.

    abstract:: ...

    journal_title:International journal of clinical pharmacy

    pub_type:

    doi:10.1007/s11096-018-0759-9

    authors:

    更新日期:2019-02-01 00:00:00

  • Community pharmacists and mental illness: a survey of service provision, stigma, attitudes and beliefs.

    abstract::Background Half of Americans experience mental illness during their lifetime. Significant opportunity exists for community pharmacists to deliver services to these patients; however, personal and practice-related barriers may prevent full engagement. Objective To assess the demographics, practice characteristics, serv...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-018-0619-7

    authors: Giannetti V,Caley CF,Kamal KM,Covvey JR,McKee J,Wells BG,Najarian DM,Dunn TJ,Vadagam P

    更新日期:2018-10-01 00:00:00

  • Hospital pharmacists' perceived beliefs and responsibilities in indication-based off-label prescribing.

    abstract::Background Off-label prescribing is prevalent in healthcare. There is a lack of understanding of pharmacists' attitudes toward the practice of off-label prescribing, especially those that are prescribed for other indications than approved ones (termed as indication-based off-label prescribing). Objective Explore hospi...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-017-0567-7

    authors: Basak R,McCaffrey DJ 3rd

    更新日期:2018-02-01 00:00:00

  • The management of ocular allergy in community pharmacies in the United Kingdom.

    abstract:BACKGROUND:Ocular allergies frequently present in pharmacy practices. However, research into the actual management of ocular allergy in pharmacies is lacking. OBJECTIVE:To determine and quantify history and symptom questioning of a patient with presumed allergic conjunctivitis and management strategies employed by pha...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-012-9742-z

    authors: Bilkhu P,Wolffsohn JS,Taylor D,Gibson E,Hirani B,Naroo SA

    更新日期:2013-04-01 00:00:00

  • Hospital pharmacists seen through the eyes of physicians: qualitative semi-structured interviews.

    abstract::Background Pharmacist-physician collaboration can lead to many positive outcomes. However, collaboration between healthcare providers is complex and rarely performed optimally. Objectives To study physician-pharmacist collaboration in hospital settings, from the physician's point of view. Setting Eight regional non-te...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-016-0395-1

    authors: Béchet C,Pichon R,Giordan A,Bonnabry P

    更新日期:2016-12-01 00:00:00

  • The role of the clinical pharmacist in the prevention of potential drug interactions in geriatric heart failure patients.

    abstract::Background The treatment of heart failure patients is very complex and includes lifestyle modification as well as different pharmacological therapies. Polypharmacy is very common in such patients and they are at increased risk of potential drug-drug interactions and associated effects such as poor adherence, complianc...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-019-00918-z

    authors: Georgiev KD,Hvarchanova N,Georgieva M,Kanazirev B

    更新日期:2019-12-01 00:00:00

  • Is pharmacovigilance of biologicals cost-effective?

    abstract::Pharmacovigilance is an essential part of the post-marketing surveillance of new biologicals. It not only requires a substantial investment of the marketing authorization holder but also of the clinical field to provide accurate safety information. Hence, does pharmacovigilance delivers value for money? This important...

    journal_title:International journal of clinical pharmacy

    pub_type: 杂志文章

    doi:10.1007/s11096-018-0695-8

    authors: Claus B

    更新日期:2018-08-01 00:00:00